Evidence map›Paper›PMID 23277511›Full record

ArticleJournal of lipid research2013

The molecular basis of ceramide-1-phosphate recognition by C2 domains.

Katherine E Ward, Nitin Bhardwaj, Mohsin Vora, Charles E Chalfant, Hui Lu, Robert V Stahelin

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Skewing cPLAScience signaling · 2023
    Article
  4. Article
  5. Phosphorylation of cPLAMolecules (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. The Cytosolic Phospholipase ABiomolecules · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Katherine E WardDepartment of Chemistry and Biochemistry and the Mike and Josie Harper Center for Cancer Research, University of Notre Dame, Notre Dame, IN.
Nitin BhardwajBioinformatics Program, Department of Bioengineering, University of Illinois at Chicago, Chicago, IL.
Mohsin VoraDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, IN.
Charles E ChalfantDepartment of Biochemistry, Medical College of Virginia Campus, Virginia Commonwealth University, the Massey Cancer Center, and Research and Development, Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, VA.
Hui LuBioinformatics Program, Department of Bioengineering, University of Illinois at Chicago, Chicago, IL.
Robert V StahelinDepartment of Chemistry and Biochemistry and the Mike and Josie Harper Center for Cancer Research, University of Notre Dame, Notre Dame, IN; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, IN.
Indiana University School of MedicineUniversity of Illinois Chicago · USUniversity of Notre Dame · USVirginia Commonwealth University Medical Center · US

Funding

Chemistry-Biochemistry-Biology Training Program at Notre DameT32GM075762 · NIGMS · UNIVERSITY OF NOTRE DAME · PI CHANG, MAYLAND F, MOBASHERY, SHAHRIAR · 2007 to 2021
$3.7M
The Role of Ceramide Kinase in Eicosanoid SynthesisR01HL072925 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHALFANT, CHARLES E. · 2004 to 2012
$3.1M
Regulation of caspase 9 RNA splicing in NSCLC cancerR01CA154314 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHALFANT, CHARLES E. · 2011 to 2014
$1.2M
The role of RNA splicing in non-small cell lung cancerI01BX001792 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI CHALFANT, CHARLES E. · 2013 to 2024
–
American Heart Association-American Stroke Association 11PRE7640028BLRD VA I01 BX001792NCI NIH HHS CA154314NCI NIH HHS R01 CA154314NHLBI NIH HHS HL072925NHLBI NIH HHS R01 HL072925NIGMS NIH HHS T32 GM075762NIGMS NIH HHS T32GM075762
6 · The paper itself

Abstract

Group IVA cytosolic phospholipase A₂ (cPLA₂α), which harbors an N-terminal lipid binding C2 domain and a C-terminal lipase domain, produces arachidonic acid from the sn-2 position of zwitterionic lipids such as phosphatidylcholine. The C2 domain has been shown to bind zwitterionic lipids, but more recently, the anionic phosphomonoester sphingolipid metabolite ceramide-1-phosphate (C1P) has emerged as a potent bioactive lipid with high affinity for a cationic patch in the C2 domain β-groove. To systematically analyze the role that C1P plays in promoting the binding of cPLA₂α-C2 to biological membranes, we employed biophysical measurements and cellular translocation studies along with mutagenesis. Biophysical and cellular translocation studies demonstrate that C1P specificity is mediated by Arg⁵⁹, Arg⁶¹, and His⁶² (an RxRH sequence) in the C2 domain. Computational studies using molecular dynamics simulations confirm the origin of C1P specificity, which results in a spatial shift of the C2 domain upon membrane docking to coordinate the small C1P headgroup. Additionally, the hydroxyl group on the sphingosine backbone plays an important role in the interaction with the C2 domain, further demonstrating the selectivity of the C2 domain for C1P over phosphatidic acid. Taken together, this is the first study demonstrating the molecular origin of C1P recognition.

Indexed as

CalciumCeramidesEicosanoidsGroup IV Phospholipases A2Molecular Dynamics SimulationProtein BindingCalciumceramide 1-phosphateCeramidesEicosanoidsGroup IV Phospholipases A2

Identifiers

PMID23277511
PMCPMC3617939
OpenAlexW2103305118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.